FT. LAUDERDALE, Fla., May 9, 2016 /PRNewswire/ -- BioTrackTHC™, a leading provider of seed-to-sale cannabis traceability technology, today announced its collaboration with the New Hampshire Department of Health and Human Services (DHHS) and Therapeutic Cannabis Program licensees for the successful openings of the state's first two Alternative Treatment Centers (ATCs).
"BioTrackTHC provided an exceptional level of support," said Jason Sidman, CEO, Sanctuary ATC. "We made the right decision working with BioTrackTHC."
BioTrackTHC's industry leading commercial system is being implemented in New Hampshire to import patient data from the DHHS through a secure FTP site, automating the process and ensuring the integrity of patient records.
"Sanctuary ATC reached out and let us know that cannabis traceability was the last missing piece that remained in the way of going live," said Patrick Vo, CEO, BioTrackTHC. "The BioTrackTHC team rallied behind them and moved quickly to support the needs of New Hampshire's Therapeutic Cannabis Program. Most importantly, the patients did not have to wait another week, or even another day, to get access to therapeutic cannabis because of the exemplary teamwork of the DHHS, the licensees, and BioTrackTHC."
Sanctuary ATC initiated operations at its Plymouth dispensary location on April 30 and Temescal Wellness, Inc., which cultivates therapeutic cannabis, opened its Dover dispensary location on May 5.
"BioTrackTHC has done an outstanding job helping Temescal utilize the program," said Anthony Parrinello, Executive Director, Temescal Wellness. "The BioTrackTHC team was prepositioned to install, train and support our team."
BioTrackTHC has been awarded six government cannabis tracking contracts for the company's seed-to-sale Traceability System for cannabis industry oversight; it is currently being utilized or in the process of being implemented by the states of Washington, Illinois, New Mexico, New York, Hawaii, and the City of Arcata, California. The company's Enterprise System for businesses is used in nearly 1,800 medical and recreational cannabis facilities in 23 states, Washington D.C., Canada, Jamaica and South America. These technologies enable government agencies and businesses to track every plant and every fraction-of-a-gram of cannabis throughout the production lifecycle—cultivation, harvest and cure, quality assurance testing, transportation, destruction, and sale—bringing transparency, accountability, and meaningful insights to cannabis operations.